Commentary: H. pylori eradication therapy after subtotal gastrectomy for gastric cancer - can the qualitative be quantified? Authors' reply.
Center for Gastric Cancer, National Cancer Center, Goyang, Korea. cij1224@ncc.re.kr.
S-J
SJ
Cho
I J
IJ
Choi
D000230:Adenocarcinoma / Q000601:surgery*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D007422:Intestines / Q000473:pathology*; D008297:Male; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D013270:Stomach / Q000473:pathology*; D013274:Stomach Neoplasms / Q000601:surgery*
D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors